O	O	0	1	[	[	O	(	O	5	NMOD	O
O	O	1	10	Molecular	Molecular	B-NP	JJ	O	4	AMOD	O
O	O	10	11	-	-	I-NP	HYPH	O	2	P	O
O	O	11	19	biologic	biologic	I-NP	JJ	O	5	NMOD	O
O	O	20	27	aspects	aspect	I-NP	NNS	O	0	ROOT	O
O	O	28	30	of	of	B-PP	IN	O	5	NMOD	O
O	O	31	42	interaction	interaction	B-NP	NN	O	6	PMOD	O
O	O	43	50	between	between	B-PP	IN	O	7	NMOD	O
O	O	51	58	nervous	nervous	B-NP	JJ	O	12	NMOD	O
O	O	59	62	and	and	I-NP	CC	O	12	NMOD	O
O	O	63	69	immune	immune	I-NP	JJ	O	12	NMOD	O
O	O	70	77	systems	system	I-NP	NNS	O	8	PMOD	O
O	O	77	78	]	]	O	)	O	5	NMOD	O

O	O	80	83	The	The	B-NP	DT	O	2	NMOD	O
O	O	84	91	problem	problem	I-NP	NN	O	30	SUB	O
O	O	92	94	of	of	B-PP	IN	O	2	NMOD	O
O	O	95	98	the	the	B-NP	DT	O	8	NMOD	O
O	O	99	104	neuro	neuro	I-NP	AFX	O	8	NMOD	O
O	O	104	105	-	-	I-NP	HYPH	O	8	NMOD	O
O	O	105	111	immuno	immuno	I-NP	NN	O	8	NMOD	O
O	O	112	124	interactions	interaction	I-NP	NNS	O	3	PMOD	O
O	O	125	127	on	on	B-PP	IN	O	8	NMOD	O
O	O	128	131	the	the	B-NP	DT	O	11	NMOD	O
O	O	132	137	level	level	I-NP	NN	O	9	PMOD	O
O	O	138	140	of	of	B-PP	IN	O	11	NMOD	O
O	O	141	144	the	the	B-NP	DT	O	14	NMOD	O
O	O	145	152	protein	protein	I-NP	NN	B-protein	12	PMOD	B-protein
O	O	153	158	trans	trans	O	AFX	I-protein	17	NMOD	I-protein
O	O	158	159	-	-	O	HYPH	I-protein	17	NMOD	I-protein
O	O	159	166	factors	factor	B-NP	NNS	I-protein	14	NMOD	I-protein
O	O	166	167	,	,	O	,	O	2	P	O
O	O	168	179	stimulating	stimulate	B-VP	VBG	O	2	NMOD	O
T1	B-Protein	180	191	interleukin	interleukin	B-NP	NN	B-DNA	29	NMOD	B-DNA
T1	I-Protein	191	192	-	-	O	HYPH	I-DNA	20	NMOD	I-DNA
T1	I-Protein	192	193	2	2	B-NP	CD	I-DNA	29	NMOD	I-DNA
O	O	194	195	(	(	O	(	I-DNA	29	NMOD	I-DNA
T2	B-Protein	195	197	IL	IL	B-NP	NN	I-DNA	29	NMOD	I-DNA
T2	I-Protein	197	198	-	-	O	HYPH	I-DNA	26	P	I-DNA
T2	I-Protein	198	199	2	2	O	CD	I-DNA	29	NMOD	I-DNA
O	O	199	200	)	)	O	)	I-DNA	29	NMOD	I-DNA
O	O	201	205	gene	gene	B-NP	NN	I-DNA	29	NMOD	I-DNA
O	O	206	216	expression	expression	I-NP	NN	O	19	OBJ	O
O	O	217	220	was	be	B-VP	VBD	O	0	ROOT	O
O	O	221	230	discussed	discuss	I-VP	VBN	O	30	VC	O
O	O	230	231	.	.	O	.	O	30	P	O

O	O	232	235	The	The	B-NP	DT	O	7	NMOD	O
O	O	236	243	physico	physico	I-NP	AFX	O	7	NMOD	O
O	O	243	244	-	-	I-NP	HYPH	O	7	NMOD	O
O	O	244	252	chemical	chemical	I-NP	JJ	O	6	AMOD	O
O	O	253	256	and	and	I-NP	CC	O	6	AMOD	O
O	O	257	267	functional	functional	I-NP	JJ	O	7	NMOD	O
O	O	268	278	parameters	parameter	I-NP	NNS	O	35	SUB	O
O	O	279	281	of	of	B-PP	IN	O	7	NMOD	O
O	O	282	285	the	the	B-NP	DT	O	13	NMOD	O
O	O	286	289	low	low	I-NP	JJ	B-protein	13	NMOD	B-protein
O	O	290	299	molecular	molecular	I-NP	JJ	I-protein	13	NMOD	I-protein
O	O	300	307	nuclear	nuclear	I-NP	JJ	I-protein	13	NMOD	I-protein
O	O	308	316	proteins	protein	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	317	318	(	(	O	(	O	25	DEP	O
O	O	318	320	SP	SP	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	321	324	and	and	I-NP	CC	O	24	NMOD	O
O	O	325	327	BP	BP	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	327	328	-	-	B-NP	HYPH	O	24	P	O
O	O	329	331	14	14	I-NP	CD	O	24	NMOD	O
O	O	331	332	,	,	I-NP	,	O	24	P	O
O	O	333	335	18	18	I-NP	CD	O	24	NMOD	O
O	O	335	336	,	,	I-NP	,	O	24	P	O
O	O	337	339	19	19	I-NP	CD	O	24	NMOD	O
O	O	340	343	kDs	kD	I-NP	NNS	O	25	DEP	O
O	O	343	344	)	)	O	)	O	13	NMOD	O
O	O	345	353	isolated	isolate	B-VP	VBN	O	13	NMOD	O
O	O	354	358	from	from	B-PP	IN	O	26	VMOD	O
O	O	359	366	splenic	splenic	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	367	370	and	and	I-NP	CC	I-cell_type	31	NMOD	I-cell_type
O	O	371	376	brain	brain	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	377	382	cells	cell	I-NP	NNS	I-cell_type	27	PMOD	I-cell_type
O	O	383	385	of	of	B-PP	IN	O	31	NMOD	O
O	O	386	395	immunized	immunize	B-NP	VBN	O	34	NMOD	O
O	O	396	400	rats	rat	I-NP	NNS	O	32	PMOD	O
O	O	401	405	were	be	B-VP	VBD	O	0	ROOT	O
O	O	406	413	studied	study	I-VP	VBN	O	35	VC	O
O	O	413	414	.	.	O	.	O	35	P	O

O	O	415	418	The	The	B-NP	DT	O	2	NMOD	O
O	O	419	426	binding	binding	I-NP	NN	O	18	NMOD	O
O	O	427	429	of	of	B-PP	IN	O	2	NMOD	O
O	O	430	435	these	these	B-NP	DT	O	5	NMOD	O
O	O	436	444	proteins	protein	I-NP	NNS	O	3	PMOD	O
O	O	445	447	to	to	B-PP	TO	O	2	NMOD	O
O	O	448	451	the	the	B-NP	DT	O	9	NMOD	O
T6	B-Entity	452	462	regulatory	regulatory	I-NP	JJ	B-DNA	9	NMOD	B-DNA
T6	I-Entity	463	469	region	region	I-NP	NN	I-DNA	6	PMOD	I-DNA
T6	I-Entity	470	472	of	of	B-PP	IN	O	9	NMOD	O
T3,T6	B-Protein,I-Entity	473	475	IL	IL	B-NP	NN	B-DNA	14	NMOD	B-DNA
T3,T6	I-Protein,I-Entity	475	476	-	-	B-NP	HYPH	I-DNA	11	NMOD	I-DNA
T3,T6	I-Protein,I-Entity	476	477	2	2	I-NP	CD	I-DNA	14	NMOD	I-DNA
T6	I-Entity	478	482	gene	gene	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	483	485	in	in	B-ADVP	FW	O	2	NMOD	O
O	O	486	491	vitro	vitro	I-ADVP	FW	O	15	AMOD	O
O	O	492	495	and	and	O	CC	O	18	NMOD	O
O	O	496	507	stimulation	stimulation	B-NP	NN	O	34	SUB	O
O	O	508	510	of	of	B-PP	IN	O	18	NMOD	O
O	O	511	514	the	the	B-NP	DT	O	24	NMOD	O
T4	B-Protein	515	517	IL	IL	I-NP	NN	B-RNA	24	NMOD	B-RNA
T4	I-Protein	517	518	-	-	B-NP	HYPH	I-RNA	24	NMOD	I-RNA
T4	I-Protein	518	523	2mRNA	2mRNA	I-NP	NN	I-RNA	24	NMOD	I-RNA
O	O	524	533	synthesis	synthesis	I-NP	NN	O	19	PMOD	O
O	O	534	536	in	in	B-PP	IN	O	18	NMOD	O
O	O	537	544	splenic	splenic	B-NP	JJ	B-cell_line	30	NMOD	B-cell_line
O	O	545	546	T	T	I-NP	NN	I-cell_line	30	NMOD	I-cell_line
O	O	546	547	-	-	I-NP	HYPH	I-cell_line	30	NMOD	I-cell_line
O	O	547	558	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	30	NMOD	I-cell_line
O	O	559	566	culture	culture	I-NP	NN	I-cell_line	25	PMOD	I-cell_line
O	O	567	569	in	in	B-PP	IN	O	18	NMOD	O
O	O	570	576	normal	normal	B-NP	JJ	O	33	NMOD	O
O	O	577	587	conditions	condition	I-NP	NNS	O	31	PMOD	O
O	O	588	592	were	be	B-VP	VBD	O	0	ROOT	O
O	O	593	598	shown	show	I-VP	VBN	O	34	VC	O
O	O	598	599	.	.	O	.	O	34	P	O

O	O	600	603	The	The	B-NP	DT	O	3	NMOD	O
O	O	604	614	protective	protective	I-NP	JJ	O	3	NMOD	O
O	O	615	621	effect	effect	I-NP	NN	O	27	SUB	O
O	O	622	624	of	of	B-PP	IN	O	3	NMOD	O
O	O	625	627	SP	SP	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	628	631	and	and	I-NP	CC	O	7	NMOD	O
O	O	632	634	BP	BP	I-NP	NN	B-protein	4	PMOD	B-protein
O	O	635	637	on	on	B-PP	IN	O	3	NMOD	O
O	O	638	641	the	the	B-NP	DT	O	13	NMOD	O
T5	B-Protein	642	644	IL	IL	I-NP	NN	B-RNA	13	NMOD	B-RNA
T5	I-Protein	644	645	-	-	B-NP	HYPH	I-RNA	13	NMOD	I-RNA
T5	I-Protein	645	650	2mRNA	2mRNA	I-NP	NN	I-RNA	13	NMOD	I-RNA
O	O	651	660	synthesis	synthesis	I-NP	NN	O	8	PMOD	O
O	O	661	663	in	in	B-PP	IN	O	13	NMOD	O
O	O	664	673	stressful	stressful	B-NP	JJ	O	16	NMOD	O
O	O	674	684	conditions	condition	I-NP	NNS	O	14	PMOD	O
O	O	685	688	and	and	B-PP	CC	O	8	PMOD	O
O	O	689	691	by	by	B-PP	IN	O	8	PMOD	O
O	O	692	695	the	the	B-NP	DT	O	23	NMOD	O
O	O	696	697	T	T	I-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	697	698	-	-	I-NP	HYPH	I-cell_type	23	NMOD	I-cell_type
O	O	698	703	cells	cell	I-NP	NNS	I-cell_type	23	NMOD	I-cell_type
O	O	704	713	treatment	treatment	I-NP	NN	O	18	PMOD	O
O	O	714	718	with	with	B-PP	IN	O	23	NMOD	O
O	O	719	722	the	the	B-NP	DT	O	26	NMOD	O
O	O	723	726	CsA	CsA	I-NP	NN	O	24	PMOD	O
O	O	727	730	was	be	B-VP	VBD	O	0	ROOT	O
O	O	731	743	demonstrated	demonstrate	I-VP	VBN	O	27	VC	O
O	O	743	744	.	.	O	.	O	27	P	O
